Full Transcript: Oncology Institute Q2 2026 Earnings Callbenzinga_article·Oct 13, 2026 at 08:36 AMSTLN-2.89%TOI0.00%
Starling Oncology highlights leadership participation at Deutsche Bank 2026 Healthcare SummitPUBT·Oct 1, 2026 at 08:15 PMSTLN-2.89%TOI0.00%
Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027PUBT·Sep 2, 2026 at 10:05 AMSTLN-2.89%
Starling Oncology executives join Wells Fargo Healthcare Conference fireside chatPUBT·Aug 24, 2026 at 01:02 PMWFC-0.75%
Starling Oncology 10% owner Jorey Chernett acquires 12,000 shares worth $78,480PUBT·Aug 17, 2026 at 02:13 PMSTLN-2.89%
Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.benzinga_article·Aug 7, 2026 at 05:53 PMSTLN-2.89%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Aug 7, 2026 at 05:05 PMCVRX+3.65%EMBC-2.19%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Aug 7, 2026 at 12:05 PMNTRA+0.64%QDEL+1.85%
Starling Oncology lifts FY 2026 revenue outlook to $650-$670 millionPUBT·Aug 6, 2026 at 09:50 PMSTLN-2.89%TOI0.00%
Oncology Institute Q2 FY26 net loss narrows 42.4% to $9.79 million; revenue rises 34.6% to $161.28 millionPUBT·Aug 6, 2026 at 09:46 PMSTLN-2.89%
Oncology Institute to trade on Nasdaq as STLN from Aug. 4, replacing TOIPUBT·Aug 3, 2026 at 12:06 PMTOI0.00%STLN-2.89%
Major Investor Quietly Boosts Position in Oncology PowerhouseTip Ranks·Jul 23, 2026 at 02:02 AMTOI0.00%STLN-2.89%
